Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-30

FDA Approved: MINOXIDIL TOPICAL SOLUTION, 5% — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved Sun Pharmaceutical’s generic minoxidil topical solution 5% for the treatment of androgenetic alopecia (ANDA 217998).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MINOXIDIL TOPICAL SOLUTION, 5% (MINOXIDIL SOLUTION)

Snippet

ORIG AP for MINOXIDIL TOPICAL SOLUTION, 5% (MINOXIDIL SOLUTION)